General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pale yellow pills imageApril 13 2018

A crack-down on the diversion of Prescription Only Medicines onto the black market has seen illicit diazepam supply drop by more than 60%.

Annual figures issued by the Medicines and Healthcare products Regulatory Agency indicate that illicit trading is down:

  • 64% for diazepam 10mg;
  • 24% for nitrazepam;
  • 20% for top-strength temazepam;
  • 14%. for zolpidem.

The MHRA data follows analysis of bulk orders of diverted medicines between January – May 2017 compared to January – May 2016. Its ongoing action is part of a programme to tackle diversion of legitimate POMs onto the criminal market, estimated to be worth £200 million. The MHRA’s enforcement team has 17 active investigations running, and 44 arrests have been made.

Multi-agency data published for drug misuse across the UK indicates that there was a substantial increase in the number of deaths registered in Scotland in 2016 that involved a benzodiazepine, rising from 191 deaths in 2015 to 426 in 2016. Benzodiazepines were associated with 406 deaths (16% of drug misuse deaths) registered in England and Wales in 2016.

The publication, ‘United Kingdom drug situation: Focal Point annual report 2017’, says:

  • there were 119,973 treatment presentations for drug misuse in the UK in 2016;
  • in England and Wales, there were 244,971 individuals recorded as being in drug treatment during 2016;
  • of all those in treatment in England and Wales, 138,422 were receiving prescribing treatment for opioid use.

Data relating to needle and syringe programmes (NSPs) includes:

  • in Scotland, there were 287 injection equipment provider outlets reporting to be operating in 2015-16, of which 219 (76%) were pharmacy-based;
  • 4.7 million needles/syringes were reported to have been distributed to people who inject drugs (PWID) in Scotland in 2015-16;
  • in Wales, 215 community pharmacies were providing NSP services;
  • 18,530 unique individuals accessed community pharmacy NSP services in Wales from April 2016 to March 2017;
  • 57% (n=1,770,451) of syringes were distributed through pharmacy-based NSP in Wales;
  • in Northern Ireland, NSP were available at 19 pharmacies which issued 35,573 packs.

Links:
MHRA announcement
‘United Kingdom drug situation: Focal Point annual report 2017’

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...